Global Companion Diagnostic IHC Assay Kits Market Growth 2026-2032
The global Companion Diagnostic IHC Assay Kits market size is predicted to grow from US$ 628 million in 2025 to US$ 1187 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
Companion diagnostic IHC assay kits are regulated in vitro diagnostic products used to detect specific protein biomarkers in formalin-fixed, paraffin-embedded tissue and other pathology specimens, with the result directly linked to patient selection for a corresponding targeted therapy, immunotherapy, or antibody-drug conjugate. A commercial assay commonly combines a clinically validated primary antibody with positive and negative controls, chromogenic or other detection reagents, and a defined interpretation procedure. Testing may be performed on fully automated, semi-automated, or manual immunohistochemistry workflows, with treatment-related results derived from staining intensity, the percentage of positive cells, composite scoring algorithms, or protein-loss patterns. Key performance requirements include analytical specificity, lot-to-lot consistency, platform compatibility, stability of clinical cutoffs, and inter-laboratory reproducibility. The principal customers are hospital pathology laboratories, independent reference laboratories, pharmaceutical developers, and diagnostic co-development programs. The average gross margin is approximately 60%.
The continued expansion of precision oncology is creating mandatory demand for tissue-based protein biomarker testing. Broader use of immune checkpoint inhibitors, HER2-directed therapies, and drugs targeting emerging markers such as CLDN18.2, FOLR1, and PTEN is extending companion diagnostic IHC beyond its traditional concentration in breast and lung cancer. Hospital pathology departments and central laboratories increasingly prioritize alignment with drug labels, validated clinical cutoffs, and interpretation manuals, creating a clear commercial boundary between regulated companion diagnostic kits and general-purpose IHC antibodies.
Product development is focused on ready-to-use reagents, standardized controls, automated staining workflows, and digital pathology-assisted interpretation. Leading suppliers typically co-develop assays with pharmaceutical companies and use installed staining platforms to standardize antibody clones, detection chemistry, and scoring algorithms across laboratories. The expansion of multiprotein panels and newer membrane-protein targets is also increasing requirements for tissue controls, cutoff validation, pathologist training, and multi-region regulatory submissions, shifting competition from individual reagent sales toward integrated platforms, assays, interpretation standards, and drug-development partnerships.
North America and Europe remain the leading markets because of concentrated regulatory approvals, strong linkage with innovative oncology drugs, and high penetration of automated pathology platforms. China and Japan are expanding through local drug indications, domestic assay approvals, and investment in pathology testing capacity. Opportunities are emerging from new antibody-drug conjugates, tumor-agnostic immunotherapy, and regional companion diagnostic development, while platform lock-in, inter-clone concordance, specimen pre-analytics, reimbursement, and frequent drug-label updates can slow commercialization. Suppliers able to support pharmaceutical development, regulatory validation, and routine laboratory implementation are positioned more favorably.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Companion Diagnostic IHC Assay Kits Industry Forecast” looks at past sales and reviews total world Companion Diagnostic IHC Assay Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected Companion Diagnostic IHC Assay Kits sales for 2026 through 2032. With Companion Diagnostic IHC Assay Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Diagnostic IHC Assay Kits industry.
This Insight Report provides a comprehensive analysis of the global Companion Diagnostic IHC Assay Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Diagnostic IHC Assay Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Diagnostic IHC Assay Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Diagnostic IHC Assay Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Diagnostic IHC Assay Kits.
This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostic IHC Assay Kits market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Companion diagnostic IHC assay kits are regulated in vitro diagnostic products used to detect specific protein biomarkers in formalin-fixed, paraffin-embedded tissue and other pathology specimens, with the result directly linked to patient selection for a corresponding targeted therapy, immunotherapy, or antibody-drug conjugate. A commercial assay commonly combines a clinically validated primary antibody with positive and negative controls, chromogenic or other detection reagents, and a defined interpretation procedure. Testing may be performed on fully automated, semi-automated, or manual immunohistochemistry workflows, with treatment-related results derived from staining intensity, the percentage of positive cells, composite scoring algorithms, or protein-loss patterns. Key performance requirements include analytical specificity, lot-to-lot consistency, platform compatibility, stability of clinical cutoffs, and inter-laboratory reproducibility. The principal customers are hospital pathology laboratories, independent reference laboratories, pharmaceutical developers, and diagnostic co-development programs. The average gross margin is approximately 60%.
The continued expansion of precision oncology is creating mandatory demand for tissue-based protein biomarker testing. Broader use of immune checkpoint inhibitors, HER2-directed therapies, and drugs targeting emerging markers such as CLDN18.2, FOLR1, and PTEN is extending companion diagnostic IHC beyond its traditional concentration in breast and lung cancer. Hospital pathology departments and central laboratories increasingly prioritize alignment with drug labels, validated clinical cutoffs, and interpretation manuals, creating a clear commercial boundary between regulated companion diagnostic kits and general-purpose IHC antibodies.
Product development is focused on ready-to-use reagents, standardized controls, automated staining workflows, and digital pathology-assisted interpretation. Leading suppliers typically co-develop assays with pharmaceutical companies and use installed staining platforms to standardize antibody clones, detection chemistry, and scoring algorithms across laboratories. The expansion of multiprotein panels and newer membrane-protein targets is also increasing requirements for tissue controls, cutoff validation, pathologist training, and multi-region regulatory submissions, shifting competition from individual reagent sales toward integrated platforms, assays, interpretation standards, and drug-development partnerships.
North America and Europe remain the leading markets because of concentrated regulatory approvals, strong linkage with innovative oncology drugs, and high penetration of automated pathology platforms. China and Japan are expanding through local drug indications, domestic assay approvals, and investment in pathology testing capacity. Opportunities are emerging from new antibody-drug conjugates, tumor-agnostic immunotherapy, and regional companion diagnostic development, while platform lock-in, inter-clone concordance, specimen pre-analytics, reimbursement, and frequent drug-label updates can slow commercialization. Suppliers able to support pharmaceutical development, regulatory validation, and routine laboratory implementation are positioned more favorably.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Companion Diagnostic IHC Assay Kits Industry Forecast” looks at past sales and reviews total world Companion Diagnostic IHC Assay Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected Companion Diagnostic IHC Assay Kits sales for 2026 through 2032. With Companion Diagnostic IHC Assay Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Diagnostic IHC Assay Kits industry.
This Insight Report provides a comprehensive analysis of the global Companion Diagnostic IHC Assay Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Diagnostic IHC Assay Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Diagnostic IHC Assay Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Diagnostic IHC Assay Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Diagnostic IHC Assay Kits.
This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostic IHC Assay Kits market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Primary Antibody-Only Kits
- Single-Marker Complete Assay Kits
- Multiprotein Panel Kits
- Other Kit Configurations
Segmentation by Detection Format:
- Single-Target Chromogenic IHC Assays
- Multiprotein Panel IHC Assays
- Dual-Stain or Multiplex IHC Assays
- Other Detection Formats
Segmentation by Staining Platform Type:
- Closed Automated Platforms
- Open Automated Platforms
- Manual or Semi-Automated Workflows
- Other Platform Types
Segmentation by Application:
- Hospital Pathology Laboratories
- Independent Reference Laboratories
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent Technologies
- Roche
- Leica Biosystems
- Amoy Diagnostics
- Nichirei Biosciences
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Companion Diagnostic IHC Assay Kits market?
- What factors are driving Companion Diagnostic IHC Assay Kits market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Companion Diagnostic IHC Assay Kits market opportunities vary by end market size?
- How does Companion Diagnostic IHC Assay Kits break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostic IHC Assay Kits Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Companion Diagnostic IHC Assay Kits by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Companion Diagnostic IHC Assay Kits by Country/Region, 2021, 2025 & 2032
2.2 Companion Diagnostic IHC Assay Kits Segment by Type
2.2.1 Primary Antibody-Only Kits
2.2.2 Single-Marker Complete Assay Kits
2.2.3 Multiprotein Panel Kits
2.2.4 Other Kit Configurations
2.2.5 Companion Diagnostic IHC Assay Kits Sales by Type
2.2.5.1 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
2.2.5.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Type (2021-2026)
2.3 Companion Diagnostic IHC Assay Kits Segment by Detection Format
2.3.1 Single-Target Chromogenic IHC Assays
2.3.2 Multiprotein Panel IHC Assays
2.3.3 Dual-Stain or Multiplex IHC Assays
2.3.4 Other Detection Formats
2.3.5 Companion Diagnostic IHC Assay Kits Sales by Detection Format
2.3.5.1 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Detection Format (2021-2026)
2.3.5.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Detection Format (2021-2026)
2.3.5.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Detection Format (2021-2026)
2.4 Companion Diagnostic IHC Assay Kits Segment by Staining Platform Type
2.4.1 Closed Automated Platforms
2.4.2 Open Automated Platforms
2.4.3 Manual or Semi-Automated Workflows
2.4.4 Other Platform Types
2.4.5 Companion Diagnostic IHC Assay Kits Sales by Staining Platform Type
2.4.5.1 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Staining Platform Type (2021-2026)
2.4.5.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Staining Platform Type (2021-2026)
2.4.5.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Staining Platform Type (2021-2026)
2.5 Companion Diagnostic IHC Assay Kits Segment by Application
2.5.1 Hospital Pathology Laboratories
2.5.2 Independent Reference Laboratories
2.5.3 Pharmaceutical and Biotechnology Companies
2.5.4 Academic and Research Institutions
2.5.5 Others
2.5.6 Companion Diagnostic IHC Assay Kits Sales by Application
2.5.6.1 Global Companion Diagnostic IHC Assay Kits Sale Market Share by Application (2021-2026)
2.5.6.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Companion Diagnostic IHC Assay Kits Breakdown Data by Company
3.1.1 Global Companion Diagnostic IHC Assay Kits Annual Sales by Company (2021-2026)
3.1.2 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Company (2021-2026)
3.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue by Company (2021-2026)
3.2.1 Global Companion Diagnostic IHC Assay Kits Revenue by Company (2021-2026)
3.2.2 Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Company (2021-2026)
3.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Company
3.4 Key Manufacturers Companion Diagnostic IHC Assay Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Companion Diagnostic IHC Assay Kits Product Location Distribution
3.4.2 Players Companion Diagnostic IHC Assay Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COMPANION DIAGNOSTIC IHC ASSAY KITS BY GEOGRAPHIC REGION
4.1 World Historic Companion Diagnostic IHC Assay Kits Market Size by Geographic Region (2021-2026)
4.1.1 Global Companion Diagnostic IHC Assay Kits Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Companion Diagnostic IHC Assay Kits Market Size by Country/Region (2021-2026)
4.2.1 Global Companion Diagnostic IHC Assay Kits Annual Sales by Country/Region (2021-2026)
4.2.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue by Country/Region (2021-2026)
4.3 Americas Companion Diagnostic IHC Assay Kits Sales Growth
4.4 APAC Companion Diagnostic IHC Assay Kits Sales Growth
4.5 Europe Companion Diagnostic IHC Assay Kits Sales Growth
4.6 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Growth
5 AMERICAS
5.1 Americas Companion Diagnostic IHC Assay Kits Sales by Country
5.1.1 Americas Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026)
5.1.2 Americas Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026)
5.2 Americas Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
5.3 Americas Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostic IHC Assay Kits Sales by Region
6.1.1 APAC Companion Diagnostic IHC Assay Kits Sales by Region (2021-2026)
6.1.2 APAC Companion Diagnostic IHC Assay Kits Revenue by Region (2021-2026)
6.2 APAC Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
6.3 APAC Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Companion Diagnostic IHC Assay Kits by Country
7.1.1 Europe Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026)
7.1.2 Europe Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026)
7.2 Europe Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
7.3 Europe Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostic IHC Assay Kits by Country
8.1.1 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026)
8.1.2 Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026)
8.2 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
8.3 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Companion Diagnostic IHC Assay Kits
10.3 Manufacturing Process Analysis of Companion Diagnostic IHC Assay Kits
10.4 Industry Chain Structure of Companion Diagnostic IHC Assay Kits
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Companion Diagnostic IHC Assay Kits Distributors
11.3 Companion Diagnostic IHC Assay Kits Customer
12 WORLD FORECAST REVIEW FOR COMPANION DIAGNOSTIC IHC ASSAY KITS BY GEOGRAPHIC REGION
12.1 Global Companion Diagnostic IHC Assay Kits Market Size Forecast by Region
12.1.1 Global Companion Diagnostic IHC Assay Kits Forecast by Region (2027-2032)
12.1.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Companion Diagnostic IHC Assay Kits Forecast by Type (2027-2032)
12.7 Global Companion Diagnostic IHC Assay Kits Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Agilent Technologies
13.1.1 Agilent Technologies Company Information
13.1.2 Agilent Technologies Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.1.3 Agilent Technologies Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Agilent Technologies Main Business Overview
13.1.5 Agilent Technologies Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.2.3 Roche Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Leica Biosystems
13.3.1 Leica Biosystems Company Information
13.3.2 Leica Biosystems Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.3.3 Leica Biosystems Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Leica Biosystems Main Business Overview
13.3.5 Leica Biosystems Latest Developments
13.4 Amoy Diagnostics
13.4.1 Amoy Diagnostics Company Information
13.4.2 Amoy Diagnostics Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.4.3 Amoy Diagnostics Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Amoy Diagnostics Main Business Overview
13.4.5 Amoy Diagnostics Latest Developments
13.5 Nichirei Biosciences
13.5.1 Nichirei Biosciences Company Information
13.5.2 Nichirei Biosciences Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.5.3 Nichirei Biosciences Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Nichirei Biosciences Main Business Overview
13.5.5 Nichirei Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostic IHC Assay Kits Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Companion Diagnostic IHC Assay Kits by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Companion Diagnostic IHC Assay Kits by Country/Region, 2021, 2025 & 2032
2.2 Companion Diagnostic IHC Assay Kits Segment by Type
2.2.1 Primary Antibody-Only Kits
2.2.2 Single-Marker Complete Assay Kits
2.2.3 Multiprotein Panel Kits
2.2.4 Other Kit Configurations
2.2.5 Companion Diagnostic IHC Assay Kits Sales by Type
2.2.5.1 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
2.2.5.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Type (2021-2026)
2.3 Companion Diagnostic IHC Assay Kits Segment by Detection Format
2.3.1 Single-Target Chromogenic IHC Assays
2.3.2 Multiprotein Panel IHC Assays
2.3.3 Dual-Stain or Multiplex IHC Assays
2.3.4 Other Detection Formats
2.3.5 Companion Diagnostic IHC Assay Kits Sales by Detection Format
2.3.5.1 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Detection Format (2021-2026)
2.3.5.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Detection Format (2021-2026)
2.3.5.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Detection Format (2021-2026)
2.4 Companion Diagnostic IHC Assay Kits Segment by Staining Platform Type
2.4.1 Closed Automated Platforms
2.4.2 Open Automated Platforms
2.4.3 Manual or Semi-Automated Workflows
2.4.4 Other Platform Types
2.4.5 Companion Diagnostic IHC Assay Kits Sales by Staining Platform Type
2.4.5.1 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Staining Platform Type (2021-2026)
2.4.5.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Staining Platform Type (2021-2026)
2.4.5.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Staining Platform Type (2021-2026)
2.5 Companion Diagnostic IHC Assay Kits Segment by Application
2.5.1 Hospital Pathology Laboratories
2.5.2 Independent Reference Laboratories
2.5.3 Pharmaceutical and Biotechnology Companies
2.5.4 Academic and Research Institutions
2.5.5 Others
2.5.6 Companion Diagnostic IHC Assay Kits Sales by Application
2.5.6.1 Global Companion Diagnostic IHC Assay Kits Sale Market Share by Application (2021-2026)
2.5.6.2 Global Companion Diagnostic IHC Assay Kits Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Companion Diagnostic IHC Assay Kits Breakdown Data by Company
3.1.1 Global Companion Diagnostic IHC Assay Kits Annual Sales by Company (2021-2026)
3.1.2 Global Companion Diagnostic IHC Assay Kits Sales Market Share by Company (2021-2026)
3.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue by Company (2021-2026)
3.2.1 Global Companion Diagnostic IHC Assay Kits Revenue by Company (2021-2026)
3.2.2 Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Company (2021-2026)
3.3 Global Companion Diagnostic IHC Assay Kits Sale Price by Company
3.4 Key Manufacturers Companion Diagnostic IHC Assay Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Companion Diagnostic IHC Assay Kits Product Location Distribution
3.4.2 Players Companion Diagnostic IHC Assay Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COMPANION DIAGNOSTIC IHC ASSAY KITS BY GEOGRAPHIC REGION
4.1 World Historic Companion Diagnostic IHC Assay Kits Market Size by Geographic Region (2021-2026)
4.1.1 Global Companion Diagnostic IHC Assay Kits Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Companion Diagnostic IHC Assay Kits Market Size by Country/Region (2021-2026)
4.2.1 Global Companion Diagnostic IHC Assay Kits Annual Sales by Country/Region (2021-2026)
4.2.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue by Country/Region (2021-2026)
4.3 Americas Companion Diagnostic IHC Assay Kits Sales Growth
4.4 APAC Companion Diagnostic IHC Assay Kits Sales Growth
4.5 Europe Companion Diagnostic IHC Assay Kits Sales Growth
4.6 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Growth
5 AMERICAS
5.1 Americas Companion Diagnostic IHC Assay Kits Sales by Country
5.1.1 Americas Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026)
5.1.2 Americas Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026)
5.2 Americas Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
5.3 Americas Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostic IHC Assay Kits Sales by Region
6.1.1 APAC Companion Diagnostic IHC Assay Kits Sales by Region (2021-2026)
6.1.2 APAC Companion Diagnostic IHC Assay Kits Revenue by Region (2021-2026)
6.2 APAC Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
6.3 APAC Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Companion Diagnostic IHC Assay Kits by Country
7.1.1 Europe Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026)
7.1.2 Europe Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026)
7.2 Europe Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
7.3 Europe Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostic IHC Assay Kits by Country
8.1.1 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026)
8.1.2 Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026)
8.2 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026)
8.3 Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Companion Diagnostic IHC Assay Kits
10.3 Manufacturing Process Analysis of Companion Diagnostic IHC Assay Kits
10.4 Industry Chain Structure of Companion Diagnostic IHC Assay Kits
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Companion Diagnostic IHC Assay Kits Distributors
11.3 Companion Diagnostic IHC Assay Kits Customer
12 WORLD FORECAST REVIEW FOR COMPANION DIAGNOSTIC IHC ASSAY KITS BY GEOGRAPHIC REGION
12.1 Global Companion Diagnostic IHC Assay Kits Market Size Forecast by Region
12.1.1 Global Companion Diagnostic IHC Assay Kits Forecast by Region (2027-2032)
12.1.2 Global Companion Diagnostic IHC Assay Kits Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Companion Diagnostic IHC Assay Kits Forecast by Type (2027-2032)
12.7 Global Companion Diagnostic IHC Assay Kits Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Agilent Technologies
13.1.1 Agilent Technologies Company Information
13.1.2 Agilent Technologies Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.1.3 Agilent Technologies Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Agilent Technologies Main Business Overview
13.1.5 Agilent Technologies Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.2.3 Roche Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Leica Biosystems
13.3.1 Leica Biosystems Company Information
13.3.2 Leica Biosystems Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.3.3 Leica Biosystems Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Leica Biosystems Main Business Overview
13.3.5 Leica Biosystems Latest Developments
13.4 Amoy Diagnostics
13.4.1 Amoy Diagnostics Company Information
13.4.2 Amoy Diagnostics Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.4.3 Amoy Diagnostics Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Amoy Diagnostics Main Business Overview
13.4.5 Amoy Diagnostics Latest Developments
13.5 Nichirei Biosciences
13.5.1 Nichirei Biosciences Company Information
13.5.2 Nichirei Biosciences Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
13.5.3 Nichirei Biosciences Companion Diagnostic IHC Assay Kits Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Nichirei Biosciences Main Business Overview
13.5.5 Nichirei Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Companion Diagnostic IHC Assay Kits Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Companion Diagnostic IHC Assay Kits Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Primary Antibody-Only Kits
Table 4. Major Players of Single-Marker Complete Assay Kits
Table 5. Major Players of Multiprotein Panel Kits
Table 6. Major Players of Other Kit Configurations
Table 7. Global Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 8. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Table 9. Global Companion Diagnostic IHC Assay Kits Revenue by Type (2021-2026) & ($ million)
Table 10. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Type (2021-2026)
Table 11. Global Companion Diagnostic IHC Assay Kits Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Single-Target Chromogenic IHC Assays
Table 13. Major Players of Multiprotein Panel IHC Assays
Table 14. Major Players of Dual-Stain or Multiplex IHC Assays
Table 15. Major Players of Other Detection Formats
Table 16. Global Companion Diagnostic IHC Assay Kits Sales by Detection Format (2021-2026) & (Units)
Table 17. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Detection Format (2021-2026)
Table 18. Global Companion Diagnostic IHC Assay Kits Revenue by Detection Format (2021-2026) & ($ million)
Table 19. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Detection Format (2021-2026)
Table 20. Global Companion Diagnostic IHC Assay Kits Sale Price by Detection Format (2021-2026) & (US$/Unit)
Table 21. Major Players of Closed Automated Platforms
Table 22. Major Players of Open Automated Platforms
Table 23. Major Players of Manual or Semi-Automated Workflows
Table 24. Major Players of Other Platform Types
Table 25. Global Companion Diagnostic IHC Assay Kits Sales by Staining Platform Type (2021-2026) & (Units)
Table 26. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Staining Platform Type (2021-2026)
Table 27. Global Companion Diagnostic IHC Assay Kits Revenue by Staining Platform Type (2021-2026) & ($ million)
Table 28. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Staining Platform Type (2021-2026)
Table 29. Global Companion Diagnostic IHC Assay Kits Sale Price by Staining Platform Type (2021-2026) & (US$/Unit)
Table 30. Global Companion Diagnostic IHC Assay Kits Sale by Application (2021-2026) & (Units)
Table 31. Global Companion Diagnostic IHC Assay Kits Sale Market Share by Application (2021-2026)
Table 32. Global Companion Diagnostic IHC Assay Kits Revenue by Application (2021-2026) & ($ million)
Table 33. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Application (2021-2026)
Table 34. Global Companion Diagnostic IHC Assay Kits Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Companion Diagnostic IHC Assay Kits Sales by Company (2021-2026) & (Units)
Table 36. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Company (2021-2026)
Table 37. Global Companion Diagnostic IHC Assay Kits Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Company (2021-2026)
Table 39. Global Companion Diagnostic IHC Assay Kits Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Companion Diagnostic IHC Assay Kits Producing Area Distribution and Sales Area
Table 41. Players Companion Diagnostic IHC Assay Kits Products Offered
Table 42. Companion Diagnostic IHC Assay Kits Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Companion Diagnostic IHC Assay Kits Sales by Geographic Region (2021-2026) & (Units)
Table 46. Global Companion Diagnostic IHC Assay Kits Sales Market Share Geographic Region (2021-2026)
Table 47. Global Companion Diagnostic IHC Assay Kits Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Companion Diagnostic IHC Assay Kits Sales by Country/Region (2021-2026) & (Units)
Table 50. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Country/Region (2021-2026)
Table 51. Global Companion Diagnostic IHC Assay Kits Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026) & (Units)
Table 54. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Country (2021-2026)
Table 55. Americas Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 57. Americas Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 58. APAC Companion Diagnostic IHC Assay Kits Sales by Region (2021-2026) & (Units)
Table 59. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Region (2021-2026)
Table 60. APAC Companion Diagnostic IHC Assay Kits Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 62. APAC Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 63. Europe Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026) & (Units)
Table 64. Europe Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 66. Europe Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 67. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026) & (Units)
Table 68. Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 70. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 71. Key Market Drivers & Growth Opportunities of Companion Diagnostic IHC Assay Kits
Table 72. Key Market Challenges & Risks of Companion Diagnostic IHC Assay Kits
Table 73. Key Industry Trends of Companion Diagnostic IHC Assay Kits
Table 74. Companion Diagnostic IHC Assay Kits Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Companion Diagnostic IHC Assay Kits Distributors List
Table 77. Companion Diagnostic IHC Assay Kits Customer List
Table 78. Global Companion Diagnostic IHC Assay Kits Sales Forecast by Region (2027-2032) & (Units)
Table 79. Global Companion Diagnostic IHC Assay Kits Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Companion Diagnostic IHC Assay Kits Sales Forecast by Country (2027-2032) & (Units)
Table 81. Americas Companion Diagnostic IHC Assay Kits Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Companion Diagnostic IHC Assay Kits Sales Forecast by Region (2027-2032) & (Units)
Table 83. APAC Companion Diagnostic IHC Assay Kits Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Companion Diagnostic IHC Assay Kits Sales Forecast by Country (2027-2032) & (Units)
Table 85. Europe Companion Diagnostic IHC Assay Kits Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Forecast by Country (2027-2032) & (Units)
Table 87. Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Companion Diagnostic IHC Assay Kits Sales Forecast by Type (2027-2032) & (Units)
Table 89. Global Companion Diagnostic IHC Assay Kits Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Companion Diagnostic IHC Assay Kits Sales Forecast by Application (2027-2032) & (Units)
Table 91. Global Companion Diagnostic IHC Assay Kits Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. Agilent Technologies Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 93. Agilent Technologies Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 94. Agilent Technologies Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Agilent Technologies Main Business
Table 96. Agilent Technologies Latest Developments
Table 97. Roche Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 98. Roche Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 99. Roche Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Roche Main Business
Table 101. Roche Latest Developments
Table 102. Leica Biosystems Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 103. Leica Biosystems Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 104. Leica Biosystems Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Leica Biosystems Main Business
Table 106. Leica Biosystems Latest Developments
Table 107. Amoy Diagnostics Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 108. Amoy Diagnostics Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 109. Amoy Diagnostics Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Amoy Diagnostics Main Business
Table 111. Amoy Diagnostics Latest Developments
Table 112. Nichirei Biosciences Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 113. Nichirei Biosciences Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 114. Nichirei Biosciences Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nichirei Biosciences Main Business
Table 116. Nichirei Biosciences Latest Developments
Table 1. Companion Diagnostic IHC Assay Kits Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Companion Diagnostic IHC Assay Kits Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Primary Antibody-Only Kits
Table 4. Major Players of Single-Marker Complete Assay Kits
Table 5. Major Players of Multiprotein Panel Kits
Table 6. Major Players of Other Kit Configurations
Table 7. Global Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 8. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Table 9. Global Companion Diagnostic IHC Assay Kits Revenue by Type (2021-2026) & ($ million)
Table 10. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Type (2021-2026)
Table 11. Global Companion Diagnostic IHC Assay Kits Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Single-Target Chromogenic IHC Assays
Table 13. Major Players of Multiprotein Panel IHC Assays
Table 14. Major Players of Dual-Stain or Multiplex IHC Assays
Table 15. Major Players of Other Detection Formats
Table 16. Global Companion Diagnostic IHC Assay Kits Sales by Detection Format (2021-2026) & (Units)
Table 17. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Detection Format (2021-2026)
Table 18. Global Companion Diagnostic IHC Assay Kits Revenue by Detection Format (2021-2026) & ($ million)
Table 19. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Detection Format (2021-2026)
Table 20. Global Companion Diagnostic IHC Assay Kits Sale Price by Detection Format (2021-2026) & (US$/Unit)
Table 21. Major Players of Closed Automated Platforms
Table 22. Major Players of Open Automated Platforms
Table 23. Major Players of Manual or Semi-Automated Workflows
Table 24. Major Players of Other Platform Types
Table 25. Global Companion Diagnostic IHC Assay Kits Sales by Staining Platform Type (2021-2026) & (Units)
Table 26. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Staining Platform Type (2021-2026)
Table 27. Global Companion Diagnostic IHC Assay Kits Revenue by Staining Platform Type (2021-2026) & ($ million)
Table 28. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Staining Platform Type (2021-2026)
Table 29. Global Companion Diagnostic IHC Assay Kits Sale Price by Staining Platform Type (2021-2026) & (US$/Unit)
Table 30. Global Companion Diagnostic IHC Assay Kits Sale by Application (2021-2026) & (Units)
Table 31. Global Companion Diagnostic IHC Assay Kits Sale Market Share by Application (2021-2026)
Table 32. Global Companion Diagnostic IHC Assay Kits Revenue by Application (2021-2026) & ($ million)
Table 33. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Application (2021-2026)
Table 34. Global Companion Diagnostic IHC Assay Kits Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Companion Diagnostic IHC Assay Kits Sales by Company (2021-2026) & (Units)
Table 36. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Company (2021-2026)
Table 37. Global Companion Diagnostic IHC Assay Kits Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Company (2021-2026)
Table 39. Global Companion Diagnostic IHC Assay Kits Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Companion Diagnostic IHC Assay Kits Producing Area Distribution and Sales Area
Table 41. Players Companion Diagnostic IHC Assay Kits Products Offered
Table 42. Companion Diagnostic IHC Assay Kits Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Companion Diagnostic IHC Assay Kits Sales by Geographic Region (2021-2026) & (Units)
Table 46. Global Companion Diagnostic IHC Assay Kits Sales Market Share Geographic Region (2021-2026)
Table 47. Global Companion Diagnostic IHC Assay Kits Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Companion Diagnostic IHC Assay Kits Sales by Country/Region (2021-2026) & (Units)
Table 50. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Country/Region (2021-2026)
Table 51. Global Companion Diagnostic IHC Assay Kits Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026) & (Units)
Table 54. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Country (2021-2026)
Table 55. Americas Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 57. Americas Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 58. APAC Companion Diagnostic IHC Assay Kits Sales by Region (2021-2026) & (Units)
Table 59. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Region (2021-2026)
Table 60. APAC Companion Diagnostic IHC Assay Kits Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 62. APAC Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 63. Europe Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026) & (Units)
Table 64. Europe Companion Diagnostic IHC Assay Kits Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 66. Europe Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 67. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Country (2021-2026) & (Units)
Table 68. Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Type (2021-2026) & (Units)
Table 70. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales by Application (2021-2026) & (Units)
Table 71. Key Market Drivers & Growth Opportunities of Companion Diagnostic IHC Assay Kits
Table 72. Key Market Challenges & Risks of Companion Diagnostic IHC Assay Kits
Table 73. Key Industry Trends of Companion Diagnostic IHC Assay Kits
Table 74. Companion Diagnostic IHC Assay Kits Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Companion Diagnostic IHC Assay Kits Distributors List
Table 77. Companion Diagnostic IHC Assay Kits Customer List
Table 78. Global Companion Diagnostic IHC Assay Kits Sales Forecast by Region (2027-2032) & (Units)
Table 79. Global Companion Diagnostic IHC Assay Kits Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Companion Diagnostic IHC Assay Kits Sales Forecast by Country (2027-2032) & (Units)
Table 81. Americas Companion Diagnostic IHC Assay Kits Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Companion Diagnostic IHC Assay Kits Sales Forecast by Region (2027-2032) & (Units)
Table 83. APAC Companion Diagnostic IHC Assay Kits Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Companion Diagnostic IHC Assay Kits Sales Forecast by Country (2027-2032) & (Units)
Table 85. Europe Companion Diagnostic IHC Assay Kits Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Forecast by Country (2027-2032) & (Units)
Table 87. Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Companion Diagnostic IHC Assay Kits Sales Forecast by Type (2027-2032) & (Units)
Table 89. Global Companion Diagnostic IHC Assay Kits Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Companion Diagnostic IHC Assay Kits Sales Forecast by Application (2027-2032) & (Units)
Table 91. Global Companion Diagnostic IHC Assay Kits Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. Agilent Technologies Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 93. Agilent Technologies Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 94. Agilent Technologies Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Agilent Technologies Main Business
Table 96. Agilent Technologies Latest Developments
Table 97. Roche Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 98. Roche Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 99. Roche Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Roche Main Business
Table 101. Roche Latest Developments
Table 102. Leica Biosystems Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 103. Leica Biosystems Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 104. Leica Biosystems Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Leica Biosystems Main Business
Table 106. Leica Biosystems Latest Developments
Table 107. Amoy Diagnostics Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 108. Amoy Diagnostics Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 109. Amoy Diagnostics Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Amoy Diagnostics Main Business
Table 111. Amoy Diagnostics Latest Developments
Table 112. Nichirei Biosciences Basic Information, Companion Diagnostic IHC Assay Kits Manufacturing Base, Sales Area and Its Competitors
Table 113. Nichirei Biosciences Companion Diagnostic IHC Assay Kits Product Portfolios and Specifications
Table 114. Nichirei Biosciences Companion Diagnostic IHC Assay Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nichirei Biosciences Main Business
Table 116. Nichirei Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Companion Diagnostic IHC Assay Kits
Figure 2. Companion Diagnostic IHC Assay Kits Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Companion Diagnostic IHC Assay Kits Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Companion Diagnostic IHC Assay Kits Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Companion Diagnostic IHC Assay Kits Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Companion Diagnostic IHC Assay Kits Sales Market Share by Country/Region (2025)
Figure 10. Companion Diagnostic IHC Assay Kits Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Primary Antibody-Only Kits
Figure 12. Product Picture of Single-Marker Complete Assay Kits
Figure 13. Product Picture of Multiprotein Panel Kits
Figure 14. Product Picture of Other Kit Configurations
Figure 15. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Type in 2026
Figure 16. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Single-Target Chromogenic IHC Assays
Figure 18. Product Picture of Multiprotein Panel IHC Assays
Figure 19. Product Picture of Dual-Stain or Multiplex IHC Assays
Figure 20. Product Picture of Other Detection Formats
Figure 21. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Detection Format in 2026
Figure 22. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Detection Format (2021-2026)
Figure 23. Product Picture of Closed Automated Platforms
Figure 24. Product Picture of Open Automated Platforms
Figure 25. Product Picture of Manual or Semi-Automated Workflows
Figure 26. Product Picture of Other Platform Types
Figure 27. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Staining Platform Type in 2026
Figure 28. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Staining Platform Type (2021-2026)
Figure 29. Companion Diagnostic IHC Assay Kits Consumed in Hospital Pathology Laboratories
Figure 30. Global Companion Diagnostic IHC Assay Kits Market: Hospital Pathology Laboratories (2021-2026) & (Units)
Figure 31. Companion Diagnostic IHC Assay Kits Consumed in Independent Reference Laboratories
Figure 32. Global Companion Diagnostic IHC Assay Kits Market: Independent Reference Laboratories (2021-2026) & (Units)
Figure 33. Companion Diagnostic IHC Assay Kits Consumed in Pharmaceutical and Biotechnology Companies
Figure 34. Global Companion Diagnostic IHC Assay Kits Market: Pharmaceutical and Biotechnology Companies (2021-2026) & (Units)
Figure 35. Companion Diagnostic IHC Assay Kits Consumed in Academic and Research Institutions
Figure 36. Global Companion Diagnostic IHC Assay Kits Market: Academic and Research Institutions (2021-2026) & (Units)
Figure 37. Companion Diagnostic IHC Assay Kits Consumed in Others
Figure 38. Global Companion Diagnostic IHC Assay Kits Market: Others (2021-2026) & (Units)
Figure 39. Global Companion Diagnostic IHC Assay Kits Sale Market Share by Application (2025)
Figure 40. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Application in 2025
Figure 41. Companion Diagnostic IHC Assay Kits Sales by Company in 2025 (Units)
Figure 42. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Company in 2025
Figure 43. Companion Diagnostic IHC Assay Kits Revenue by Company in 2025 ($ millions)
Figure 44. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Company in 2025
Figure 45. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Geographic Region (2021-2026)
Figure 46. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Geographic Region in 2025
Figure 47. Americas Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 48. Americas Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 49. APAC Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 50. APAC Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 51. Europe Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 52. Europe Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 53. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 54. Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 55. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Country in 2025
Figure 56. Americas Companion Diagnostic IHC Assay Kits Revenue Market Share by Country (2021-2026)
Figure 57. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 58. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 59. United States Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 60. Canada Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 61. Mexico Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 62. Brazil Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 63. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Region in 2025
Figure 64. APAC Companion Diagnostic IHC Assay Kits Revenue Market Share by Region (2021-2026)
Figure 65. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 66. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 67. China Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 68. Japan Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 69. South Korea Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 70. Southeast Asia Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 71. India Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 72. Australia Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 73. China Taiwan Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 74. Europe Companion Diagnostic IHC Assay Kits Sales Market Share by Country in 2025
Figure 75. Europe Companion Diagnostic IHC Assay Kits Revenue Market Share by Country (2021-2026)
Figure 76. Europe Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 77. Europe Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 78. Germany Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 79. France Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 80. UK Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 81. Italy Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 82. Russia Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 83. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Market Share by Country (2021-2026)
Figure 84. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 85. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 86. Egypt Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 87. South Africa Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 88. Israel Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 89. Turkey Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 90. GCC Countries Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 91. Manufacturing Cost Structure Analysis of Companion Diagnostic IHC Assay Kits in 2026
Figure 92. Manufacturing Process Analysis of Companion Diagnostic IHC Assay Kits
Figure 93. Industry Chain Structure of Companion Diagnostic IHC Assay Kits
Figure 94. Channels of Distribution
Figure 95. Global Companion Diagnostic IHC Assay Kits Sales Market Forecast by Region (2027-2032)
Figure 96. Global Companion Diagnostic IHC Assay Kits Revenue Market Share Forecast by Region (2027-2032)
Figure 97. Global Companion Diagnostic IHC Assay Kits Sales Market Share Forecast by Type (2027-2032)
Figure 98. Global Companion Diagnostic IHC Assay Kits Revenue Market Share Forecast by Type (2027-2032)
Figure 99. Global Companion Diagnostic IHC Assay Kits Sales Market Share Forecast by Application (2027-2032)
Figure 100. Global Companion Diagnostic IHC Assay Kits Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Companion Diagnostic IHC Assay Kits
Figure 2. Companion Diagnostic IHC Assay Kits Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Companion Diagnostic IHC Assay Kits Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Companion Diagnostic IHC Assay Kits Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Companion Diagnostic IHC Assay Kits Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Companion Diagnostic IHC Assay Kits Sales Market Share by Country/Region (2025)
Figure 10. Companion Diagnostic IHC Assay Kits Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Primary Antibody-Only Kits
Figure 12. Product Picture of Single-Marker Complete Assay Kits
Figure 13. Product Picture of Multiprotein Panel Kits
Figure 14. Product Picture of Other Kit Configurations
Figure 15. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Type in 2026
Figure 16. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Single-Target Chromogenic IHC Assays
Figure 18. Product Picture of Multiprotein Panel IHC Assays
Figure 19. Product Picture of Dual-Stain or Multiplex IHC Assays
Figure 20. Product Picture of Other Detection Formats
Figure 21. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Detection Format in 2026
Figure 22. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Detection Format (2021-2026)
Figure 23. Product Picture of Closed Automated Platforms
Figure 24. Product Picture of Open Automated Platforms
Figure 25. Product Picture of Manual or Semi-Automated Workflows
Figure 26. Product Picture of Other Platform Types
Figure 27. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Staining Platform Type in 2026
Figure 28. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Staining Platform Type (2021-2026)
Figure 29. Companion Diagnostic IHC Assay Kits Consumed in Hospital Pathology Laboratories
Figure 30. Global Companion Diagnostic IHC Assay Kits Market: Hospital Pathology Laboratories (2021-2026) & (Units)
Figure 31. Companion Diagnostic IHC Assay Kits Consumed in Independent Reference Laboratories
Figure 32. Global Companion Diagnostic IHC Assay Kits Market: Independent Reference Laboratories (2021-2026) & (Units)
Figure 33. Companion Diagnostic IHC Assay Kits Consumed in Pharmaceutical and Biotechnology Companies
Figure 34. Global Companion Diagnostic IHC Assay Kits Market: Pharmaceutical and Biotechnology Companies (2021-2026) & (Units)
Figure 35. Companion Diagnostic IHC Assay Kits Consumed in Academic and Research Institutions
Figure 36. Global Companion Diagnostic IHC Assay Kits Market: Academic and Research Institutions (2021-2026) & (Units)
Figure 37. Companion Diagnostic IHC Assay Kits Consumed in Others
Figure 38. Global Companion Diagnostic IHC Assay Kits Market: Others (2021-2026) & (Units)
Figure 39. Global Companion Diagnostic IHC Assay Kits Sale Market Share by Application (2025)
Figure 40. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Application in 2025
Figure 41. Companion Diagnostic IHC Assay Kits Sales by Company in 2025 (Units)
Figure 42. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Company in 2025
Figure 43. Companion Diagnostic IHC Assay Kits Revenue by Company in 2025 ($ millions)
Figure 44. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Company in 2025
Figure 45. Global Companion Diagnostic IHC Assay Kits Sales Market Share by Geographic Region (2021-2026)
Figure 46. Global Companion Diagnostic IHC Assay Kits Revenue Market Share by Geographic Region in 2025
Figure 47. Americas Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 48. Americas Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 49. APAC Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 50. APAC Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 51. Europe Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 52. Europe Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 53. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales 2021-2026 (Units)
Figure 54. Middle East & Africa Companion Diagnostic IHC Assay Kits Revenue 2021-2026 ($ millions)
Figure 55. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Country in 2025
Figure 56. Americas Companion Diagnostic IHC Assay Kits Revenue Market Share by Country (2021-2026)
Figure 57. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 58. Americas Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 59. United States Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 60. Canada Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 61. Mexico Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 62. Brazil Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 63. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Region in 2025
Figure 64. APAC Companion Diagnostic IHC Assay Kits Revenue Market Share by Region (2021-2026)
Figure 65. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 66. APAC Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 67. China Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 68. Japan Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 69. South Korea Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 70. Southeast Asia Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 71. India Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 72. Australia Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 73. China Taiwan Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 74. Europe Companion Diagnostic IHC Assay Kits Sales Market Share by Country in 2025
Figure 75. Europe Companion Diagnostic IHC Assay Kits Revenue Market Share by Country (2021-2026)
Figure 76. Europe Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 77. Europe Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 78. Germany Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 79. France Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 80. UK Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 81. Italy Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 82. Russia Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 83. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Market Share by Country (2021-2026)
Figure 84. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Market Share by Type (2021-2026)
Figure 85. Middle East & Africa Companion Diagnostic IHC Assay Kits Sales Market Share by Application (2021-2026)
Figure 86. Egypt Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 87. South Africa Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 88. Israel Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 89. Turkey Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 90. GCC Countries Companion Diagnostic IHC Assay Kits Revenue Growth 2021-2026 ($ millions)
Figure 91. Manufacturing Cost Structure Analysis of Companion Diagnostic IHC Assay Kits in 2026
Figure 92. Manufacturing Process Analysis of Companion Diagnostic IHC Assay Kits
Figure 93. Industry Chain Structure of Companion Diagnostic IHC Assay Kits
Figure 94. Channels of Distribution
Figure 95. Global Companion Diagnostic IHC Assay Kits Sales Market Forecast by Region (2027-2032)
Figure 96. Global Companion Diagnostic IHC Assay Kits Revenue Market Share Forecast by Region (2027-2032)
Figure 97. Global Companion Diagnostic IHC Assay Kits Sales Market Share Forecast by Type (2027-2032)
Figure 98. Global Companion Diagnostic IHC Assay Kits Revenue Market Share Forecast by Type (2027-2032)
Figure 99. Global Companion Diagnostic IHC Assay Kits Sales Market Share Forecast by Application (2027-2032)
Figure 100. Global Companion Diagnostic IHC Assay Kits Revenue Market Share Forecast by Application (2027-2032)
